{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:44:20Z","timestamp":1782866660535,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005609","name":"University of Turku","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005609","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10096-026-05471-y","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:53:43Z","timestamp":1773863623000},"page":"1827-1835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Screening and treatment practices for tuberculosis infection in Nordic, Baltic and Central European countries and Ukraine in 2023"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6691-556X","authenticated-orcid":false,"given":"Thijs","family":"Feuth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6812-178X","authenticated-orcid":false,"given":"Iiris","family":"Rajalahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Vauhkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Nordstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3460-1299","authenticated-orcid":false,"given":"Melanie","family":"Stecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0983-8315","authenticated-orcid":false,"given":"Piret","family":"Viiklepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0898-1939","authenticated-orcid":false,"given":"Elmira","family":"Gurbanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dclla-Karin","family":"Nurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Terleeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1413-8970","authenticated-orcid":false,"given":"Tuula","family":"Vasankari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"5471_CR1","volume-title":"Tuberculosis surveillance and monitoring in Europe 2024\u2009\u2013\u20092022 data","author":"European Centre for Disease Prevention and Control, WHO Regional Office for Europe","year":"2024","unstructured":"European Centre for Disease Prevention and Control, WHO Regional Office for Europe (2024) Tuberculosis surveillance and monitoring in Europe 2024\u2009\u2013\u20092022 data. European Centre for Disease Prevention and Control, WHO Regional Office for Europe, Copenhagen and Stockholm"},{"key":"5471_CR2","unstructured":"WorldHealth Organization (2024) Global Tuberculosis Report 2024. Geneva. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/7292c91e-ffb0-4cef-ac39-0200f06961ea\/content"},{"issue":"3","key":"5471_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/eurpub\/cku208","volume":"25","author":"A Odone","year":"2015","unstructured":"Odone A, Tillmann T, Sandgren A, Williams G, Rechel B, Ingleby D et al (2015) Tuberculosis among migrant populations in the European Union and the European Economic Area. Eur J Public Health 25(3):506\u2013512","journal-title":"Eur J Public Health"},{"key":"5471_CR4","doi-asserted-by":"publisher","unstructured":"CohenA, Mathiasen VD, Sch\u00f6n T, Wejse C (2019) The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J 54(3). https:\/\/doi.org\/10.1183\/13993003.00655-2019","DOI":"10.1183\/13993003.00655-2019"},{"key":"5471_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijid.2022.05.029","volume":"122","author":"C Ding","year":"2022","unstructured":"Ding C, Hu M, Guo W, Hu W, Li X, Wang S et al (2022) Prevalence trends of latent tuberculosis infection at the global, regional, and country levels from 1990\u20132019. Int J Infect Dis 122:46\u201362","journal-title":"Int J Infect Dis"},{"key":"5471_CR6","unstructured":"WorldHealth Organization (2024) WHO consolidated guidelines on tuberculosis. Module 1: Prevention - Tuberculosis preventive treatment, second edition. 2 ed. Geneva. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/314ddea2-6fc2-4ff0-9357-a038feca1d31\/content"},{"issue":"1","key":"5471_CR7","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1186\/s12889-020-08907-y","volume":"20","author":"R Proen\u00e7a","year":"2020","unstructured":"Proen\u00e7a R, Mattos Souza F, Lisboa Bastos M, Caetano R, Braga JU, Faerstein E et al (2020) Active and latent tuberculosis in refugees and asylum seekers: a systematic review and meta-analysis. BMC Public Health 20(1):838","journal-title":"BMC Public Health"},{"key":"5471_CR8","doi-asserted-by":"publisher","unstructured":"MargineanuI, Rustage K, Noori T, Zenner D, Greenaway C, Pareek M et al (2022) Country-specific approaches to latent tuberculosis screening targeting migrants in EU\/EEA* countries: A survey of national experts, September 2019 to February 2020. Euro Surveill 27(12). https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.12.2002070","DOI":"10.2807\/1560-7917.ES.2022.27.12.2002070"},{"issue":"1","key":"5471_CR9","doi-asserted-by":"publisher","first-page":"230357","DOI":"10.1183\/20734735.0357-2023","volume":"20","author":"S Braga","year":"2024","unstructured":"Braga S, Vieira M, Barbosa P, Ramos JP, Duarte R (2024) Tuberculosis screening in the European migrant population: a scoping review of current practices. Breathe (Sheff) 20(1):230357","journal-title":"Breathe (Sheff)"},{"issue":"8","key":"5471_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.5588\/ijtldopen.24.0350","volume":"1","author":"A Matteelli","year":"2024","unstructured":"Matteelli A, Mkrtchyan Z, Masini T, Hovhannesyan A, Kuchukhidze G, Ahmedov S et al (2024) TB prevention activities in the WHO European Region. IJTLD Open 1(8):349\u2013354","journal-title":"IJTLD Open"},{"issue":"1","key":"5471_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/thorax-2023-220502","volume":"79","author":"P Haldar","year":"2023","unstructured":"Haldar P, Ahyow L, Dedicoat M (2023) Responding to the tuberculosis risk of forced mass migration from Ukraine: a complex challenge with no single solution. Thorax 79(1):5\u20136","journal-title":"Thorax"},{"key":"5471_CR12","doi-asserted-by":"publisher","unstructured":"StoychevaK, Cristea V, K\u00f6dm\u00f6n C, Rosales-Klintz S, Zenner D, Vasiliu A et al (2024) Tuberculosis in people of Ukrainian origin in the European Union and the European Economic Area, 2019 to 2022. Euro Surveill 29(12). https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.12.2400094","DOI":"10.2807\/1560-7917.ES.2024.29.12.2400094"},{"issue":"8","key":"5471_CR13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.5588\/ijtld.23.0073","volume":"27","author":"B H\u00e4cker","year":"2023","unstructured":"H\u00e4cker B, Breuer C, Priwitzer M, Otto-Knapp R, Bauer T (2023) TB screening of Ukrainian refugees in Germany. Int J Tuberc Lung Dis 27(8):641\u2013642","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"5471_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5588\/ijtldopen.24.0062","volume":"1","author":"G De Vries","year":"2024","unstructured":"De Vries G, Guthmann JP, H\u00e4cker B, Hauer B, Nordstrand K, Nowinski A et al (2024) TB among refugees from Ukraine in European countries. IJTLD Open 1(4):166\u2013173","journal-title":"IJTLD Open"},{"key":"5471_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2807\/1560-7917.ES.2025.30.34.2500633","volume":"30","author":"K Nordstrand","year":"2025","unstructured":"Nordstrand K, Berild JD (2025) Increase in tuberculosis notification rates among newly arriving male Ukrainian refugees to Norway, 2022 to 2024. Euro Surveill 30:34","journal-title":"Euro Surveill"},{"key":"5471_CR16","volume-title":"Cost-effectiveness analysis of programmatic screening strategies for latent tuberculosis infection in the EU\/EEA","author":"European Center for Disease Prevention and Control (ECDC)","year":"2018","unstructured":"European Center for Disease Prevention and Control (ECDC) (2018) Cost-effectiveness analysis of programmatic screening strategies for latent tuberculosis infection in the EU\/EEA. European Centre for Disease Prevention and Control, Stockholm"},{"issue":"1","key":"5471_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6901a1","volume":"69","author":"TR Sterling","year":"2020","unstructured":"Sterling TR, Njie G, Zenner D, Cohn DL, Reves R, Ahmed A et al (2020) Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep 69(1):1\u201311","journal-title":"MMWR Recomm Rep"},{"key":"5471_CR18","doi-asserted-by":"publisher","unstructured":"KunstH, Lange B, Hovardovska O, Bockey A, Zenner D, Andersen AB et al (2025) Tuberculosis in adult migrants in Europe: a TBnet consensus statement. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01612-2024","DOI":"10.1183\/13993003.01612-2024"},{"issue":"8","key":"5471_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.puhe.2006.05.002","volume":"120","author":"DW MacPherson","year":"2006","unstructured":"MacPherson DW, Gushulak BD (2006) Balancing prevention and screening among international migrants with tuberculosis: population mobility as the major epidemiological influence in low-incidence nations. Public Health 120(8):712\u2013723","journal-title":"Public Health"},{"key":"5471_CR20","doi-asserted-by":"publisher","first-page":"106980","DOI":"10.1016\/j.ijid.2024.02.023","volume":"141S","author":"A Dadu","year":"2024","unstructured":"Dadu A, Yedilbayev A, Migliori GB, Ahmedov S, Falzon D, den Boon S et al (2024) PASS to End TB in Europe: Accelerated efforts on prevention and systematic screening to end tuberculosis in the WHO European Region by 2030. Int J Infect Dis 141S:106980","journal-title":"Int J Infect Dis"},{"key":"5471_CR21","doi-asserted-by":"publisher","unstructured":"GreenawayC, Pareek M, Abou Chakra CN, Walji M, Makarenko I, Alabdulkarim B et al (2018) The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU\/EEA: a systematic review. Euro Surveill 23(14). https:\/\/doi.org\/10.2807\/1560-7917.ES.2018.23.14.17-00542","DOI":"10.2807\/1560-7917.ES.2018.23.14.17-00542"},{"issue":"1","key":"5471_CR22","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1186\/s12889-018-6038-9","volume":"18","author":"P Tiittala","year":"2018","unstructured":"Tiittala P, Tuomisto K, Puumalainen T, Lyytik\u00e4inen O, Ollgren J, Snellman O et al (2018) Public health response to large influx of asylum seekers: implementation and timing of infectious disease screening. BMC Public Health 18(1):1139","journal-title":"BMC Public Health"},{"issue":"1","key":"5471_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12890-022-02149-x","volume":"22","author":"J Mahon","year":"2022","unstructured":"Mahon J, Beale S, Holmes H, Arber M, Nikolayevskyy V, Alagna R et al (2022) A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations. BMC Pulm Med 22(1):375","journal-title":"BMC Pulm Med"},{"issue":"5","key":"5471_CR24","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/S1473-3099(22)00214-6","volume":"22","author":"E Holt","year":"2022","unstructured":"Holt E (2022) Tuberculosis services disrupted by war in Ukraine. Lancet Infect Dis 22(5):e129","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"5471_CR25","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/S1473-3099(18)30117-8","volume":"18","author":"F Seedat","year":"2018","unstructured":"Seedat F, Hargreaves S, Nellums LB, Ouyang J, Brown M, Friedland JS (2018) How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review. Lancet Infect Dis 18(9):e259\u2013e71","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"5471_CR26","doi-asserted-by":"publisher","first-page":"EVIDoa2400190","DOI":"10.1056\/EVIDoa2400190","volume":"4","author":"T Duong","year":"2025","unstructured":"Duong T, Brigden J, Simon Schaaf H, Garden F, Marais BJ, Anh Nguyen T et al (2025) A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis. NEJM Evid 4(1):EVIDoa2400190","journal-title":"NEJM Evid"},{"key":"5471_CR27","doi-asserted-by":"publisher","unstructured":"MasiniT, Kanchar A, Mirzayev F, Viney K, Yedilbayev A, Zignol M et al (2022) Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally. Eur Respir J 60(2). https:\/\/doi.org\/10.1183\/13993003.01227-2022","DOI":"10.1183\/13993003.01227-2022"},{"issue":"11","key":"5471_CR28","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJMoa1806808","volume":"380","author":"S Swindells","year":"2019","unstructured":"Swindells S, Ramchandani R, Gupta A, Benson CA, Leon-Cruz J, Mwelase N et al (2019) One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. N Engl J Med 380(11):1001\u20131011","journal-title":"N Engl J Med"},{"issue":"5","key":"5471_CR29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S2352-4642(21)00052-3","volume":"5","author":"AA Malik","year":"2021","unstructured":"Malik AA, Farooq S, Jaswal M, Khan H, Nasir K, Fareed U et al (2021) Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study. Lancet Child Adolesc Health 5(5):350\u2013356","journal-title":"Lancet Child Adolesc Health"},{"key":"5471_CR30","doi-asserted-by":"crossref","unstructured":"ZumlaA, Sahu S, Yeboah-Manu D, Goletti D, Nyasulu PS, Mfinanga S et al (2025) Breaking dependency: strengthening the global tuberculosis response in the face of USAID cuts. Lancet. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0140673625003356?via%3Dihub","DOI":"10.1016\/S0140-6736(25)00335-6"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05471-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05471-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05471-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:45:24Z","timestamp":1782863124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05471-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5471"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05471-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data of the study were obtained from governmental institutes. This study only includes country-level data on healthcare and does not involve research on human subjects. Therefore, the WMA Declaration of Helsinki does not apply, and the study was not subject to ethics evaluation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}